Clincosm LogoSign in Get a demo

Analysis of the Impact of the Undernutrition on the Cerebral Infarct in Thrombolized Patients

Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Completed
CT.gov ID
NCT03303820
Collaborator
(none)
73
Enrollment
1
Location
15.1
Actual Duration (Months)
4.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Many clinical trials show that 30 to 50 % of the hospitalized patients are undernourished in various degrees. This prevalence didn't change since 15-20 years The fact is that the present undernutrition in the admission deteriorates during the hospitalization.

Besides, the cerebral vascular accident (AVC) complicates the first days, in at least 50 % of the cases, the disorders of the gulp, which are a risk factor of acquired undernutrition. The nutrition holds an important place in the therapeutic coverage of the AVC. Nevertheless, the link between the undernutrition the entrance and the evolution of the AVC is at the moment only little known. The purpose is to study the impact of the undernutrition in the entrance to the hospital (undernutrition previous to the AVC), on the gravity and the evolution

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    73 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Analysis of the Impact of the Undernutrition on the Cerebral Infarct in Thrombolized Patients
    Actual Study Start Date :
    May 27, 2016
    Actual Primary Completion Date :
    May 27, 2017
    Actual Study Completion Date :
    Aug 31, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Rankin score [Day 1; last day of hospitalisation]

      measurement of Rankin score at the entrance and at the end of hospitalisation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    • patient admitted in hospital for vascular cerebral accident in 2015

    • thrombolytic treatment

    Exclusion Criteria:

    • no thrombolytic treatment

    • transcient ischaemic attack

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Groupe Hospitalier Paris Saint Joseph Paris Ile-de-France France 75014

    Sponsors and Collaborators

    • Groupe Hospitalier Paris Saint Joseph

    Investigators

    • Study Director: ZUBER Mathieu, Professor, GHPSJ

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Groupe Hospitalier Paris Saint Joseph
    ClinicalTrials.gov Identifier:
    NCT03303820
    Other Study ID Numbers:
    • ADIT
    First Posted:
    Oct 6, 2017
    Last Update Posted:
    Oct 6, 2017
    Last Verified:
    Oct 1, 2017
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Cerebral Infarction
    Thrombosis
    Malnutrition

    Study Results

    No Results Posted as of Oct 6, 2017